Widespread distribution of a single drug rifampicin formulation of inferior bioavailability in South Africa.
Bhaduri
Jaydip
J
D000995:Antitubercular Agents / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D001682:Biological Availability; D006801:Humans; D012293:Rifampin / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D013019:South Africa; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D000995:Antitubercular Agents; D012293:Rifampin